Trial | NCT03090048  Report issue

Title

Vitamin A and Azithromycin for Acne Vulgaris
Treatment of Acne for Cases Resistant to Currently Available Measures Via Vitamin A With or Without Azithromycin in Topical Formulations

  • Phase

    Early Phase 1

  • Study Type

    Interventional

  • Status

    Not yet recruiting

  • Study Participants

    30
Patients seen with acne lesions not having responded to existing treatments will be offered a placebo or a topical preparation consisting of Vitamin A USP with or without Azithromycin for a duration of 4-6 months USP for the objective of resolving the lesions without systemic side effects and via weekly follow-ups.
The concentrations of the active ingredients is based on the enclosed articles and the formulations have been modified with an objective of minimizing the side effects.
Study Started
Apr 01
2021
Anticipated
Primary Completion
Aug 24
2021
Anticipated
Study Completion
Oct 31
2021
Anticipated
Last Update
Feb 25
2021

Drug Vitamin A

Vitamin A 2-3 % concentration

  • Other names: retinyl palmitate

Drug Azithromycin

azithromycin monohydrate

  • Other names: azithromycin monohydrate

Azithromycin Active Comparator

azithromycin monohydrate

Vitamin A Experimental

retinyl palmitate USP

Azithromycin with Vitamin A Experimental

USP grade ingredients

Criteria 

Inclusion Criteria:

Patients with active lesions

Exclusion Criteria:

Patients on a treatment
Asymptomatic patients
No Results Posted